tiprankstipranks
Bergenbio Asa (BRRGF)
:BRRGF
US Market

BerGenBio ASA (BRRGF) Financial Statements

Compare
48 Followers

BerGenBio ASA Financial Overview

BerGenBio ASA's market cap is currently $29.15M. The company's EPS TTM is $-0.458; its P/E ratio is ―; BerGenBio ASA is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue
Gross Profit-----
Operating Income
EBITDA$ 92.57M$ 94.84M$ 71.48M$ 59.97M$ 30.64M
Net Income$ 62.87M$ 64.21M$ 52.51M$ 43.74M$ 21.23M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 6.46B$ 6.08B$ 5.15B$ 3.94B$ 3.00B
Total Debt$ 278.37M$ 147.89M$ 261.52M$ 295.00M$ 166.02M
Net Debt$ 278.37M$ 147.89M$ 261.52M$ 295.00M$ 166.02M
Total Liabilities$ 5.82B$ 5.40B$ 4.51B$ 3.40B$ 2.64B
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 75.22M$ 88.59M$ 48.20M$ 36.87M$ 27.44M
Operating Cash Flow$ 90.03M$ 95.72M$ 51.19M$ 44.70M$ 31.50M
Investing Cash Flow
Financing Cash Flow
Currency in USD

BerGenBio ASA Earnings and Revenue History

BerGenBio ASA Debt to Assets

BerGenBio ASA Cash Flow

BerGenBio ASA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis